Relationship between pulmonary function and physical performance among community‐living people: results from Look‐up 7+ study

Landi, Francesco; Salini, Sara; Zazzara, Maria Beatrice; Martone, Anna Maria; Fabrizi, Sofia; Bianchi, Mariangela; Tosato, Matteo; Picca, Anna; Calvani, Riccardo; Marzetti, Emanuele

doi:10.1002/jcsm.12485

Cited by 20 publications

(22 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In older people, low inspiratory muscle endurance is associated with the low walking performance ( 27 ). The time taken to perform a task in chair stand tests shows a positive correlation with FVC, FEV1, and peak expiratory flow (PEF) ( 39 ). Physical performance, balance, and gait scores in low PEF group were significantly lower compared to a normal PEF group ( 40 ).…”

Section: Age-related Respiratory Sarcopeniamentioning

confidence: 99%

See 1 more Smart Citation

Respiratory Sarcopenia and Sarcopenic Respiratory Disability: Concepts, Diagnosis, and Treatment

Nagano

Wakabayashi

Maeda

et al. 2021

The Journal of nutrition, health and aging

View full text Add to dashboard Cite

The condition of muscle fiber atrophy and weakness that occurs in respiratory muscles along with systemic skeletal muscle with age is known as respiratory sarcopenia. The Japanese Working Group of Respiratory Sarcopenia of the Japanese Association of Rehabilitation Nutrition narratively reviews these areas, and proposes the concept and diagnostic criteria. We have defined respiratory sarcopenia as "wholebody sarcopenia and low respiratory muscle mass followed by low respiratory muscle strength and/or low respiratory function." Respiratory sarcopenia can be caused by various factors such as aging, decreased activity, undernutrition, disease, cachexia, and iatrogenic causes. We have also created an algorithm for diagnosing respiratory sarcopenia. Respiratory function decreases with age in healthy older people, along with low respiratory muscle mass and strength. We have created a new term, "Presbypnea," meaning a decline in respiratory function with aging. Minor functional respiratory disability due to aging, such as that indicated by a modified Medical Research Council level 1 (troubled by shortness of breath when hurrying or walking straight up hill), is an indicator of presbypnea. We also define sarcopenic respiratory disability as "a disability with deteriorated respiratory function that results from respiratory sarcopenia." Sarcopenic respiratory disability is diagnosed if respiratory sarcopenia is present with functional disability. Cases of respiratory sarcopenia without functional disability are diagnosed as "at risk of sarcopenic respiratory disability." Functional disability is defined as a modified Medical Research Council grade of 2 or more. Rehabilitation nutrition, treatment that combines rehabilitation and nutritional management, may be adequate to prevent and treat respiratory sarcopenia and sarcopenic respiratory disability.

show abstract

Section: Age-related Respiratory Sarcopeniamentioning

confidence: 99%

“…Vital capacity and FVC are common measurement methods for respiratory function. We adopted FVC as a measure of respiratory function, as FVC is associated with sarcopenia ( 39 , 70 ). As with MIP, FVC varies by body size, so it is considered adaptable to local standards ( 21 ).…”

Section: Diagnosis Of Respiratory Sarcopenia and Sarcopenic Respiratomentioning

confidence: 99%

Respiratory Sarcopenia and Sarcopenic Respiratory Disability: Concepts, Diagnosis, and Treatment

Nagano

Wakabayashi

Maeda

et al. 2021

The Journal of nutrition, health and aging

View full text Add to dashboard Cite

show abstract

“…The time taken to complete the task(s) was measured using a handheld stopwatch and was used for the analyses. 17,18…”

Section: Muscle Strength Testingmentioning

confidence: 99%

Normative values of muscle strength across ages in a ‘real world’ population: results from the longevity check‐up 7+ project

Landi

Calvani

Martone

et al. 2020

J cachexia sarcopenia muscle

Self Cite

View full text Add to dashboard Cite

Background Low muscle strength is a powerful predictor of negative health-related events and a key component of sarcopenia. The lack of normative values for muscle strength across ages hampers the practical appraisal of this parameter. The aim of the present study was to produce normative values for upper and lower extremity muscle strength across a wide spectrum of ages, in a large sample of community-dwellers recruited in the Longevity checkup (Lookup) 7+ project. Methods Lookup 7+ is an ongoing project that started in June 2015 and conducted in unconventional settings (i.e. exhibitions, malls, and health promotion campaigns) across Italy with the aim of fostering the adoption of healthy lifestyles in the general population. Candidate participants are eligible for enrolment if they are 18+ years and provide written informed consent. Upper and lower extremity muscle strength is assessed by handgrip strength and five-repetition chair-stand [5 × sit-to-stand (STS)] tests, respectively. Cross-sectional centile and normative values for handgrip strength and 5 × STS tests from age 18 to 80+ years were generated for the two genders. Smoothed normative curves for the two tests were constructed for men and women using the lambda-mu-sigma method. Results From 1 June 2015 to 30 May 2019, 11 448 participants were enrolled. The mean age of participants was 55.6 years (standard deviation: 11.5 years; range: 18-98 years), and 6382 (56%) were women. Normative values for handgrip strength and the 5 × STS test, both absolute and normalized by body mass index, were obtained for men and women, stratified by age groups. Values of upper and lower extremity muscle strength across ages identified three periods in life: an increase to peak in young age and early adulthood (18-24 years), preservation through midlife (25-44 years), and a decline from midlife onwards (45+ years). Conclusions Our study established age-specific and gender-specific percentile reference values for handgrip strength and the 5 × STS test. The normative curves generated can be used to interpret the assessment of muscle strength in everyday practice for the early detection of individuals with or at risk of sarcopenia.

show abstract

“…We focused on SMI alone, which is a biomarker of sarcopenia. A previous study has reported the relationship between pulmonary function and physical performance 28) . Second, it was difficult to establish the exclusion criteria for older adults who had various comorbid diseases and a complex medical history.…”

Section: Discussionmentioning

confidence: 99%

Association between skeletal muscle mass index and lung function/respiratory muscle strength in older adults requiring long-term care or support

et al. 2020

View full text Add to dashboard Cite

Relationship between pulmonary function and physical performance among community‐living people: results from Look‐up 7+ study

Cited by 20 publications

References 33 publications

Respiratory Sarcopenia and Sarcopenic Respiratory Disability: Concepts, Diagnosis, and Treatment

Respiratory Sarcopenia and Sarcopenic Respiratory Disability: Concepts, Diagnosis, and Treatment

Normative values of muscle strength across ages in a ‘real world’ population: results from the longevity check‐up 7+ project

Association between skeletal muscle mass index and lung function/respiratory muscle strength in older adults requiring long-term care or support

Contact Info

Product

Resources

About